Majority of drug-related problems identified during medication review are not associated with STOPP/START criteria

42Citations
Citations of this article
167Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Purpose: STOPP and START criteria identify potential inappropriate prescribing and potential prescribing omissions. It is unknown whether STOPP/START criteria identify all drug-related problems. This study aims to determine to what extent STOPP/START correspond to drug-related problems (DRPs) identified during a full clinical medication review. Methods: In 13 Dutch community pharmacies, 457 community-dwelling patients aged ≥ 65 years and using ≥ 5 drugs, received a full clinical medication review. Community pharmacists identified potential DRPs and recommendations by implicit criteria. After completion, all identified DRPs and recommendations were compared with STOPP and START criteria by investigators. Results: The total number of potential DRPs identified by community pharmacists was 1656 in 457 patients (mean 3.6 per patient). Eighty-one percent of DRPs were not associated with STOPP/START criteria. The percentage of START criteria present in identified DRPs was higher than the percentage of STOPP criteria (13 vs. 5.7 %, p∈

Cite

CITATION STYLE

APA

Verdoorn, S., Kwint, H. F., Faber, A., Gussekloo, J., & Bouvy, M. L. (2015). Majority of drug-related problems identified during medication review are not associated with STOPP/START criteria. European Journal of Clinical Pharmacology, 71(10), 1255–1262. https://doi.org/10.1007/s00228-015-1908-x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free